← Back to Search

TRAC for Cancer Survivors

N/A

Recruiting

Led By Carolyn Lauckner, PhD

Research Sponsored by Laurie McLouth

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with cancer between age 15-39

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial will test the feasibility of an 8-week motivational interviewing mHealth intervention, Tracking and Reducing Alcohol Consumption (TRAC), to reduce alcohol use among rural adolescent and young adult (AYA) cancer survivors during post-treatment survivorship.

Who is the study for?

This trial is for rural adolescent and young adult cancer survivors, aged 15-39, who are 1-10 years post-treatment and engage in risky alcohol use. It's not suitable for individuals with severe psychopathology.Check my eligibility

What is being tested?

The study is testing TRAC (Tracking and Reducing Alcohol Consumption), a mobile health intervention using motivational interviewing to reduce alcohol use over a period of four weeks among participants.See study design

What are the potential side effects?

Since this trial involves a behavioral intervention rather than medication, traditional physical side effects are not expected; however, participants may experience emotional or psychological discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was diagnosed with cancer between the ages of 15 and 39.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Enrollment

Secondary outcome measures

Intervention adherence

Retention

Other outcome measures

Alcohol negative consequences

Alcohol positive consequences

Alcohol use

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TRAC: Tracking and Reducing Alcohol ConsumptionExperimental Treatment1 Intervention

The TRAC intervention focuses on increasing motivation and building skills to reduce alcohol use and involves 4, 30-minute sessions with an interventionist done via video chat or phone. Participants will complete smartphone-based self-monitoring of alcohol use. Each morning, participants complete a mobile survey indicating if they drank the previous day and if so, how many drinks they had. Surveys will be programmed using REDcap and sent via a link in the reminder text message. Additionally, participants will be prompted each evening and asked to complete a breathalyzer reading using a mobile app to determine blood alcohol content (BAC). If safety concerns are identified (e.g., BAC ≥0.30; blackouts), the interventionist will refer the AYA to a licensed provider with expertise in substance use treatment.

Group II: ControlActive Control1 Intervention

Participants in the control group will receive educational materials regarding alcohol consumption and its link to cancer . They will also participate in smartphone monitoring of alcohol use on the same schedule as participants in the intervention group. This will allow us to compare daily alcohol use data between the two conditions and evaluate the added component of weekly counseling in TRAC.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Laurie McLouthLead Sponsor

3 Previous Clinical Trials

367 Total Patients Enrolled

Carolyn LaucknerLead Sponsor

2 Previous Clinical Trials

455 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,665 Previous Clinical Trials

40,926,158 Total Patients Enrolled

Media Library

TRAC: Tracking and Reducing Alcohol Consumption Clinical Trial Eligibility Overview. Trial Name: NCT05087875 — N/A

Cancer Research Study Groups: TRAC: Tracking and Reducing Alcohol Consumption, Control

Cancer Clinical Trial 2023: TRAC: Tracking and Reducing Alcohol Consumption Highlights & Side Effects. Trial Name: NCT05087875 — N/A

TRAC: Tracking and Reducing Alcohol Consumption 2023 Treatment Timeline for Medical Study. Trial Name: NCT05087875 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are people who are above the age of 25 years old allowed to participate in this research project?

"For this particular clinical trial, only patients between 18-39 years old fit the inclusion criteria. However, there are 84 other trials that welcome applicants under 18 and 613 for seniors 65+."

Answered by AI

Are there any patients you are still looking to enroll in this research program?

"The trial in question, which was first posted on November 1st 2022 and updated most recently on September 26th of the same year, is not recruiting patients at this time. Although, it's worth mentioning that there are 747 other clinical trials enrolling participants as we speak."

Answered by AI

Are there any specific types of people who would be more likely to benefit from this clinical trial?

"To be eligible for this study, participants must between 18-39 years old, have had cancer diagnosed within the last 10 years, live in a rural area, and meet the criteria for risky alcohol use. 40 people will be accepted in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluating an mHealth Intervention for Reducing Alcohol Use Among Rural Adolescent and Young Adult Cancer Survivors

Carolyn Lauckner 2022. "Evaluating an mHealth Intervention for Reducing Alcohol Use Among Rural Adolescent and Young Adult Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05087875.

All > Alcoholism